Cite
HARVARD Citation
Macaluso, F. et al. (n.d.). OC.06.5: Mycophenolate Mofetil is a Valid Option in Patients with Inflammatory Bowel Disease Resistant to TNF-Alpha Inhibitors and Conventional Immunosuppressants. Digestive and liver disease. pp. e92-e93. [Online].